Benjamin Gilbert Neel MD
Director, Laura and Isaac Perlmutter Cancer Center
Join to View Full Profile
77 Avenue Louis Pasteur# NrbBoston, MA 02115
Phone+1 617-667-2823
Fax+1 212-263-9190
Dr. Neel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1983 - 1987
Weill Cornell MedicineClass of 1983
Certifications & Licensure
MA State Medical License 1984 - 2026
Publications & Presentations
PubMed
- Generation of actionable, cancer-specific neoantigens from KRAS(G12C) with adagrasib.Lorenzo Maso, Epsa Rajak, Takamitsu Hattori, Zhengshan Hu, Akiko Koide
Proceedings of the National Academy of Sciences of the United States of America. 2025-08-05 - 3 citationsAberrant ERK signaling in astrocytes impairs learning and memory in RASopathy-associated BRAF mutant mouse models.Minkyung Kang, Jihye Choi, Jeongho Han, Toshiyuki Araki, Soo-Whee Kim
The Journal of Clinical Investigation. 2025-04-15 - 1 citationsCharacterization of tumour heterogeneity through segmentation-free representation learning on multiplexed imaging data.Jimin Tan, Hortense Le, Jiehui Deng, Yingzhuo Liu, Yuan Hao
Nature Biomedical Engineering. 2025-03-01
Journal Articles
- The Gp1ba-Cre Transgenic Mouse: A New Model to Delineate Platelet and Leukocyte FunctionsBenjamin Neel, MD, Blood
Press Mentions
NYU Grossman Rescinds Program Acceptances After Losing Federal GrantMay 14th, 2025- MSK Research Highlights, January 17, 2025January 17th, 2025
- NYU Langone Health’s Perlmutter Cancer Center Continues to Grow in Brooklyn, Provide Care to Diverse PopulationsApril 5th, 2023
- Join now to see all
Grant Support
- Exploiting synthetic lethality to enhance KRAS inhibitor therapy of cancerNEW YORK UNIVERSITY SCHOOL OF MEDICINE2025–2027
- Molecular ontology of drug tolerant persisters in HER2 positive breast cancer - Resubmission - 1NEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2026
- Molecular ontology of drug tolerant persisters in HER2 positive breast cancer - Resubmission - 1NEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2026
- New Approaches to Modeling and Targeting Cyclin E-amplified High-Grade Serous Tubo-Ovarian CarcinomaNEW YORK UNIVERSITY SCHOOL OF MEDICINE2020–2025
- Response and resistance to SHP2 inhibitors alone and in combination in Non-Small Cell Lung CancerNEW YORK UNIVERSITY SCHOOL OF MEDICINE2020–2025
- Signal Transduction By Non-Transmembrane PtpsNational Cancer Institute2008–2012
- The RAS/MAPK Pathway In Cardiovascular Disease.National Heart, Lung, And Blood Institute2011
- Human SHP2 (PTPN11) Mutations And Cardiac Valve DevelopmentNational Heart, Lung, And Blood Institute2009–2010
- Role Of GAB2 And SHP2 In Hematopoietic SignallingNational Cancer Institute2008–2010
- Human SHP2 (PTPN11) Mutations And Cardiac Valve DevelopmentNational Heart, Lung, And Blood Institute2007–2008
- Role Of GAB2 And SHP2 In Hematopoietic SignallingNational Cancer Institute2006–2008
- Signal Transduction By Non-Transmembrane PtpsNational Cancer Institute2004–2007
- EM Localization Of PTP1B &Rtk &Ptp1b InteractionsNational Center For Research Resources2004–2006
- Role Of PTP1B In Body Mass RegulationNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2005
- Role Of BAG2 And SHP2 In Hematopoietic SignallingNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2004
- Training Program In Cancer BiologyNational Cancer Institute2000–2004
- Signal Transduction By Non-Transmembrane PtpsNational Cancer Institute1999–2003
- GAB2 And SHP2 In Hematopoiesis And LeukemogenesisNational Institute Of Diabetes And Digestive And Kidney Diseases2002
- 2002 Faseb Meeting On Protein PhosphatasesNational Cancer Institute2002
- Molecular And Genetic Basis Of Cell ProliferationNational Cancer Institute2001
- Role Of Ptpu And SHPTP2 In Endothelial CellsNational Heart, Lung, And Blood Institute1997–2001
- Hematologic Diseases Resulting From Defects Of Tyrosine PhosphatasesNational Institute Of Diabetes And Digestive And Kidney Diseases1996–2001
- Regulation Of B Cell Signaling By Shptp-1National Cancer Institute1996–2000
- Regulation Of EPO Receptor Signaling By SH-PTP1National Institute Of Diabetes And Digestive And Kidney Diseases1996–1999
- Signal Transduction By Non-Transmembrane PTP SNational Cancer Institute1994–1998
- Molecular Analysis Of Supression Of TransformationNational Cancer Institute1989–1993
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
